Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lakshmi Nayak, Md

Clinical trials sponsored by Lakshmi Nayak, Md, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a Brain-Penetrating drug tackle recurrent CNS lymphoma? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Can a Brain-Penetrating drug tackle recurrent CNS lymphoma?

Disease control Recruiting now

This phase 2 trial is testing whether paxalisib (GDC-0084), an oral drug taken daily, can shrink or control tumors in people with recurrent or refractory primary central nervous system lymphoma (PCNSL) — a rare type of non-Hodgkin lymphoma that starts in the brain or spinal cord.…

Phase 2 • Sponsor: Lakshmi Nayak, MD • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC